MicroTech Medical (Hangzhou) Co., Ltd. (HKG:2235)
Hong Kong · Delayed Price · Currency is HKD 6.54
-0.05 (-0.68%)
Sep 11, 2026, 3:57 PM HKT
HKG:2235 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,740 | 3,314 | 2,556 | 2,704 | 4,151 | 10,814 | |
Market Cap Growth | -24.16% | 29.67% | -5.45% | -34.87% | -61.61% | - |
Enterprise Value | 1,050 | 1,459 | 635 | 488 | 1,687 | 10,044 |
Last Close Price | 6.60 | 7.93 | 6.10 | 6.40 | 9.75 | 25.40 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 27.27 | 74.18 | - | - | - | - |
Forward PE | 17.74 | 61.27 | - | - | - | - |
PS Ratio | 2.86 | 4.51 | 6.95 | 9.69 | 21.15 | 58.19 |
PB Ratio | 1.16 | 1.48 | 1.22 | 1.19 | 1.66 | 3.92 |
P/TBV Ratio | 1.18 | 1.50 | 1.24 | 1.21 | 1.67 | 3.95 |
P/OCF Ratio | - | 91.34 | - | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.10 | 1.99 | 1.73 | 1.75 | 8.60 | 54.05 |
EV/EBITDA Ratio | 10.25 | 115.02 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.04 | 0.03 | 0 | 0 | 0 | 0 |
Debt / EBITDA Ratio | 0.84 | 5.44 | - | - | - | - |
Net Debt / Equity Ratio | -0.72 | -0.73 | -0.86 | -0.92 | -0.92 | -0.96 |
Net Debt / EBITDA Ratio | -16.58 | -129.92 | 13.83 | 10.27 | 18.57 | 41.14 |
Net Debt / FCF Ratio | - | 234.90 | 8.37 | 12.36 | 13.75 | 34.79 |
Asset Turnover | 0.37 | 0.30 | 0.16 | 0.11 | 0.08 | 0.10 |
Inventory Turnover | 4.43 | 4.81 | 3.58 | 2.49 | 1.85 | 3.06 |
Quick Ratio | 5.73 | 5.97 | 10.94 | 21.05 | 26.49 | 26.52 |
Current Ratio | 6.19 | 6.39 | 11.41 | 21.67 | 27.50 | 27.12 |
Return on Equity (ROE) | 4.13% | 2.01% | -3.13% | -5.85% | -1.57% | -3.24% |
Return on Assets (ROA) | 2.08% | -0.03% | -3.94% | -5.48% | -3.25% | -2.42% |
Return on Invested Capital (ROIC) | 13.17% | -0.22% | -62.01% | -116.25% | -91.82% | -70.95% |
Return on Capital Employed (ROCE) | 3.70% | 0.00% | -6.80% | -9.50% | -5.40% | -2.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 3.49% | 1.35% | -2.63% | -5.09% | -0.95% | -0.55% |
FCF Yield | - | -0.21% | -8.49% | -6.23% | -4.05% | -0.70% |
Payout Ratio | - | 0.06% | - | - | - | - |
Buyback Yield / Dilution | 5.44% | 1.63% | 2.39% | 1.59% | -17.39% | -21.79% |